In addition, this approach provides a meaningful theoretical basis for the treatment of solid tumors with Anti-MICB-CAR-NK cells and offers a potential pathway for the clinical treatment of solid tumors such as pancreatic cancer. This evidence concerns the gene MICB and familial pancreatic carcinoma.